Reviewed by Emily Henderson, B.Sc. Jun 7 2022 Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a rare but fatal bone marrow cancer, researchers reported June 7. Ruben Mesa, MD, FACP, executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson...
Tag: <span>Myelofibrosis</span>
Post
Insider attacks: Purdue developing new treatment options for millions with autoimmune diseases
Living with an autoimmune disease can feel like an insider is attacking your body. An estimated 24 million people in the United States are affected by autoimmune diseases, a group of diseases in which the person’s immune system attacks part of the person’s own body. Credit: CC0 Public Domain Now, Purdue University researchers have developed...